Cargando…
Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach
Hepatocellular carcinoma (HCC) is the world’s third most widespread cancer. Currently available circulating biomarkers for this silently progressing malignancy are not sufficiently specific and sensitive to meet all clinical needs. There is an imminent and pressing need for the identification of nov...
Autores principales: | Awan, Faryal Mehwish, Naz, Anam, Obaid, Ayesha, Ali, Amjad, Ahmad, Jamil, Anjum, Sadia, Janjua, Hussnain Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586137/ https://www.ncbi.nlm.nih.gov/pubmed/26414287 http://dx.doi.org/10.1371/journal.pone.0138913 |
Ejemplares similares
-
MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance
por: Awan, Faryal Mehwish, et al.
Publicado: (2017) -
Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development
por: Ikram, Aqsa, et al.
Publicado: (2022) -
Mutation-Structure-Function Relationship Based Integrated Strategy Reveals the Potential Impact of Deleterious Missense Mutations in Autophagy Related Proteins on Hepatocellular Carcinoma (HCC): A Comprehensive Informatics Approach
por: Awan, Faryal Mehwish, et al.
Publicado: (2017) -
Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets
por: Hassan, Afreenish, et al.
Publicado: (2016) -
Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy
por: Obaid, Ayesha, et al.
Publicado: (2018)